Janus Henderson Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $17.6M | Buy |
|
|||||
|
2024
Q4 | $3.57M | Hold |
|
|||||
|
2024
Q3 | $3.13M | Buy |
|
|||||
|
2024
Q2 | $2.75M | Sell |
|
|||||
|
2024
Q1 | $27.8M | Sell |
|
|||||
|
2023
Q4 | $35M | Buy |
|
|||||
|
2023
Q3 | $25M | Sell |
|
|||||
|
2023
Q2 | $38.7M | Sell |
|
|||||
|
2023
Q1 | $41.9M | Buy |
|
|||||
|
2022
Q4 | $15.2M | Sell |
|
|||||
|
2022
Q3 | $21.1M | Buy |
|
|||||
|
2022
Q2 | $10.7M | Buy |
|
|||||
|
2022
Q1 | $7.77M | Sell |
|
|||||
|
2021
Q4 | $7.73M | Buy |
|
|||||
|
2021
Q3 | $5.45M | Buy |
|
|||||
|
2021
Q2 | $5.39M | Buy |
|
|||||
|
2021
Q1 | $3.98M | Buy |
|
|||||
|
2020
Q4 | $1.49M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $552K | Hold |
|
|||||
|
2017
Q2 | $435K | Buy |
|